We were able to externally validate our findings in HUNT using another high-sensitivity cardiac troponin I assay, and we demonstrated that for both assays the trajectories of cardiac troponin prior to cardiovascular death differed to those individuals who died due to non-cardiovascular disease or survivors. This evidence concerns the gene TNNI3 and cardiovascular disorder.